ECILC vs ONCSM Comparison
Price, market cap, valuation, profitability and leverage metrics of ECILC and ONCSM side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | ECILC | ONCSM | Sector median |
|---|---|---|---|
| Last price (TL) | 64.05 | 82.45 | 18.72 |
| Daily change | −6.50% | −7.46% | −6.49% |
| Market cap | TRY 43.9B | TRY 2B | TRY 4.3B |
| P/E | — | 26.70 | 17.31 |
| P/B | 0.68 | 4.21 | 1.08 |
| Dividend yield | 2.04% | — | 0.90% |
| Return on equity | −3.08% | 18.26% | 1.78% |
| Free float | 22.02% | 40.86% | 37.21% |
Popular Comparisons
Related Pages
About the ECILC vs ONCSM Comparison
Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and ONCSM (Oncosem Onkolojik Sistemler) side by side as of Sep 28, 2026, 15:01. Of the 15 metrics compared, ECILC leads in 5 and ONCSM leads in 10.
Highlights: Daily change: ECILC leads (−6.50% vs −7.46%). Market cap: ECILC leads (TRY 43.9B vs TRY 2B). P/B: ECILC leads (0.68 vs 4.21). EV/EBITDA: ONCSM leads (7.50 vs 165.19). EV/Sales: ONCSM leads (4.76 vs 9.35). Gross margin: ONCSM leads (54.30% vs 37.83%). EBITDA margin (annual): ONCSM leads (41.91% vs 11.49%). Net margin (annual): ONCSM leads (10.83% vs −20.86%).
Frequently Asked Questions
Is ECILC or ONCSM cheaper?
By P/E, Tie is cheaper (— vs 26.70); by P/B, ECILC trades at the lower multiple (0.68 vs 4.21).
Which is more profitable, ECILC or ONCSM?
Annual net margin is −20.86% for ECILC and 10.83% for ONCSM; return on equity is −3.08% for ECILC and 18.26% for ONCSM.
Which is more leveraged, ECILC or ONCSM?
The leverage ratio is 18.92 for ECILC and 44.59 for ONCSM; net debt/EBITDA is 1.37 for ECILC and 0.48 for ONCSM. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.